stars 1 stars 2 stars 3

StimulusBio enables quantitative control of immune cell activation and expansion. Our patent-pending Programmable Cellular Interface (sbPCI™) technology presents stimulatory, co-stimulatory, and signaling molecules in a defined, tunable format, allowing researchers to precisely control signal presentation without genetic modification. The associated CellPilot™ product portfolio supports CAR-T, TIL, NK, CAR-NK, feeder cell replacement, and stem cell applications by providing a flexible, biocompatible platform for designing and optimizing cell therapies. We are currently offering early-access products and seeking additional collaborators.

Stimulus Bio Questions

Mimi Healy is the CEO of Stimulus Bio.

9 people are employed at Stimulus Bio.

Stimulus Bio is based in Houston, Texas.

Top Stimulus Bio Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users